| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |